Kieran Gallahue Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kieran Gallahue.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kieran Gallahue. Kieran Gallahue is President, Global in RESMED INC ($RMD) and Director in Edwards Lifesciences Corp ($EW) and Director in ARENA PHARMACEUTICALS INC ($ARNA) and in Intersect ENT, Inc. ($XENT) and Director in Intersect ENT, Inc. ($XENT) and Executive Chairman in Intersect ENT, Inc. ($XENT) and Chairman and CEO in CAREFUSION Corp ($CFN) and in Envista Holdings Corp ($NVST) and Director in Envista Holdings Corp ($NVST).
Latest Insider Trading Transactions of Kieran Gallahue
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARNA, CFN, EW, NVST, XENT, RMD
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 3,067 | 0 | 9,283 | 6.2 K to 9.3 K (+49.34 %) |
May 07 2021 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 818 | 0 | 3,433 | 2.6 K to 3.4 K (+31.28 %) |
May 07 2021 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,615 | 0 | 2,615 | 0 to 2.6 K |
Mar 18 2021 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 21.00 | 3,390 | 71,190 | 3,390 | ||
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,446 | 0 | 9,844 | 7.4 K to 9.8 K (+33.06 %) |
Jun 08 2020 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 11.84 | 9,666 | 114,445 | 9,666 | ||
Jun 08 2020 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Grant | A | 0.00 | 5,011 | 0 | 34,273 | 29.3 K to 34.3 K (+17.12 %) | |
May 29 2020 | NVST | Envista Holdings C ... | GALLAHUE KIERAN | Option Exercise | A | 0.00 | 8,230 | 0 | 8,230 | ||
May 11 2020 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Gift | G | 0.00 | 1,737 | 0 | 17,471 | 15.7 K to 17.5 K (+11.04 %) |
May 11 2020 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 345 | 0 | 1,446 | 1.1 K to 1.4 K (+31.34 %) |
May 11 2020 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,101 | 0 | 1,101 | 0 to 1.1 K |
May 11 2020 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Gift | G | 0.00 | 1,737 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
Dec 20 2019 | NVST | Envista Holdings C ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,035 | 0 | 2,035 | 0 to 2 K |
Oct 02 2019 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Executive Chairman | Option Exercise | A | 17.01 | 82,387 | 1,401,403 | 82,387 | |
Oct 02 2019 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Executive Chairman | Grant | A | 0.00 | 17,202 | 0 | 29,262 | 12.1 K to 29.3 K (+142.64 %) |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,654 | 0 | 7,398 | 4.7 K to 7.4 K (+55.94 %) |
May 13 2019 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 414 | 0 | 1,737 | 1.3 K to 1.7 K (+31.29 %) |
May 13 2019 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,323 | 0 | 1,323 | 0 to 1.3 K |
May 08 2019 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Executive Chairman | Option Exercise | A | 25.10 | 180,096 | 4,520,410 | 180,096 | |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 44.79 | 4,583 | 205,273 | 4,583 | |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Option Exercise | A | 44.79 | 2,500 | 111,975 | 2,500 | |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 3,070 | 0 | 4,744 | 1.7 K to 4.7 K (+183.39 %) |
Jul 10 2018 | ARNA | ARENA PHARMACEUTIC ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,674 | 0 | 1,674 | 0 to 1.7 K |
Jun 07 2018 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 42.05 | 3,473 | 146,040 | 3,473 | ||
Jun 07 2018 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Grant | A | 0.00 | 1,514 | 0 | 12,060 | 10.5 K to 12.1 K (+14.36 %) | |
May 22 2018 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Gift | G | 0.00 | 2,034 | 0 | 13,600 | 11.6 K to 13.6 K (+17.59 %) |
May 22 2018 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 479 | 0 | 2,134 | 1.7 K to 2.1 K (+28.94 %) |
May 22 2018 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,655 | 0 | 1,655 | 0 to 1.7 K |
May 22 2018 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Gift | G | 0.00 | 2,034 | 0 | 0 | 2 K to 0 (-100.00 %) |
Jun 05 2017 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 26.05 | 6,035 | 157,212 | 6,035 | ||
Jun 05 2017 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Grant | A | 0.00 | 2,546 | 0 | 10,546 | 8 K to 10.5 K (+31.83 %) | |
May 15 2017 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Option Exercise | A | 110.59 | 2,352 | 260,108 | 2,352 | |
May 15 2017 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 2,034 | 0 | 2,034 | 0 to 2 K |
Feb 06 2017 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Buy | P | 90.10 | 3,000 | 270,300 | 9,042 | 6 K to 9 K (+49.65 %) |
Jan 20 2017 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 13.05 | 13,248 | 172,886 | 13,248 | ||
Dec 01 2016 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Buy | P | 84.63 | 3,000 | 253,900 | 6,042 | 3 K to 6 K (+98.62 %) |
Jun 06 2016 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Option Exercise | A | 13.79 | 12,500 | 172,375 | 12,500 | ||
May 17 2016 | XENT | Intersect ENT, Inc ... | GALLAHUE KIERAN | Buy | P | 12.64 | 8,000 | 101,111 | 8,000 | 0 to 8 K | |
May 17 2016 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 583 | 0 | 5,566 | 5 K to 5.6 K (+11.70 %) |
May 17 2016 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,941 | 0 | 4,983 | 3 K to 5 K (+63.81 %) |
May 19 2015 | EW | Edwards Lifescienc ... | GALLAHUE KIERAN | Director | Grant | A | 0.00 | 1,521 | 0 | 1,521 | 0 to 1.5 K |
Apr 10 2015 | XENT | Intersect ENT, Inc ... | Gallahue Kieran | Director | Option Exercise | A | 25.31 | 25,000 | 632,750 | 25,000 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 43.97 | 350,997 | 15,433,338 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 36.17 | 266,430 | 9,636,773 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 26.79 | 159,464 | 4,272,041 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 0.00 | 44,348 | 0 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 0.00 | 35,942 | 0 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 0.00 | 23,330 | 0 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 0.00 | 79,131 | 0 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 0.00 | 107,824 | 0 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | D | 0.00 | 139,978 | 0 | 0 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | A | 0.00 | 79,131 | 0 | 79,131 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | A | 0.00 | 107,824 | 0 | 107,824 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | A | 0.00 | 139,978 | 0 | 139,978 | |
Mar 19 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Sell | D | 0.00 | 740,251 | 0 | 0 | 740.3 K to 0 (-100.00 %) |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | M | 36.17 | 133,215 | 4,818,387 | 266,430 | |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | M | 26.79 | 318,928 | 8,544,081 | 159,464 | |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | M | 25.56 | 503,306 | 12,864,501 | 0 | |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Option Exercise | M | 27.84 | 533,110 | 14,841,782 | 0 | |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Payment of Exercise | F | 59.73 | 1,103,089 | 65,887,506 | 740,251 | 1.8 M to 740.3 K (-59.84 %) |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Buy | M | 36.17 | 133,215 | 4,818,387 | 1,843,340 | 1.7 M to 1.8 M (+7.79 %) |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Buy | M | 26.79 | 318,928 | 8,544,081 | 1,710,125 | 1.4 M to 1.7 M (+22.92 %) |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Buy | M | 25.56 | 503,306 | 12,864,501 | 1,391,197 | 887.9 K to 1.4 M (+56.69 %) |
Mar 13 2015 | CFN | CAREFUSION Corp | Gallahue Kieran | Chairman and CEO | Buy | M | 27.84 | 533,110 | 14,841,782 | 887,891 | 354.8 K to 887.9 K (+150.26 %) |
Feb 23 2015 | EW | Edwards Lifescienc ... | Gallahue Kieran | Director | Option Exercise | A | 133.72 | 5,376 | 718,879 | 5,376 | |
Nov 13 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | A | 42.05 | 300,000 | 12,615,000 | 632,000 | |
Feb 23 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 12,600 | 201,411 | 332,000 | |
Feb 23 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 12,400 | 198,214 | 344,600 | |
Feb 23 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 49.27 | 12,600 | 620,827 | 2,658 | 15.3 K to 2.7 K (-82.58 %) |
Feb 23 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 12,600 | 201,411 | 15,258 | 2.7 K to 15.3 K (+474.04 %) |
Feb 23 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 49.50 | 12,400 | 613,800 | 2,658 | 15.1 K to 2.7 K (-82.35 %) |
Feb 23 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 12,400 | 198,214 | 15,058 | 2.7 K to 15.1 K (+466.52 %) |
Feb 16 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 10,000 | 159,850 | 357,000 | |
Feb 16 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 50.57 | 10,000 | 505,702 | 2,658 | 12.7 K to 2.7 K (-79.00 %) |
Feb 16 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 10,000 | 159,850 | 12,658 | 2.7 K to 12.7 K (+376.22 %) |
Feb 14 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 15,000 | 239,775 | 367,000 | |
Feb 14 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 49.50 | 15,000 | 742,518 | 2,658 | 17.7 K to 2.7 K (-84.95 %) |
Feb 14 2007 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 15,000 | 239,775 | 17,658 | 2.7 K to 17.7 K (+564.33 %) |
Nov 15 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 50,000 | 799,250 | 382,000 | |
Nov 15 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | A | 46.19 | 75,000 | 3,464,250 | 432,000 | |
Nov 15 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 46.48 | 50,000 | 2,324,090 | 2,658 | 52.7 K to 2.7 K (-94.95 %) |
Nov 15 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 50,000 | 799,250 | 52,658 | 2.7 K to 52.7 K (+1,881.11 %) |
May 09 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 50,000 | 799,250 | 357,000 | |
May 09 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 47.54 | 50,000 | 2,376,800 | 2,658 | 52.7 K to 2.7 K (-94.95 %) |
May 09 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 50,000 | 799,250 | 52,658 | 2.7 K to 52.7 K (+1,881.11 %) |
Feb 10 2006 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | A | 38.50 | 50,000 | 1,925,000 | 407,000 | |
Nov 18 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 15.99 | 25,000 | 399,625 | 363,000 | |
Nov 18 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 41.07 | 25,000 | 1,026,665 | 1,933 | 26.9 K to 1.9 K (-92.82 %) |
Nov 18 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 15.99 | 25,000 | 399,625 | 26,993 | 2 K to 27 K (+1,254.39 %) |
Sep 12 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 31.97 | 5,000 | 159,850 | 191,000 | |
Sep 12 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 72.90 | 5,000 | 364,500 | 836 | 5.8 K to 836 (-85.68 %) |
Sep 12 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 31.97 | 5,000 | 159,850 | 5,836 | 836 to 5.8 K (+598.09 %) |
Sep 12 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 31.97 | 5,000 | 159,850 | 191,000 | |
Sep 12 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 72.90 | 5,000 | 364,500 | 836 | 5.8 K to 836 (-85.68 %) |
Sep 12 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 31.97 | 5,000 | 159,850 | 5,836 | 836 to 5.8 K (+598.09 %) |
Feb 09 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 31.97 | 5,000 | 159,850 | 196,000 | |
Feb 09 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 59.00 | 5,000 | 295,000 | 407 | 5.4 K to 407 (-92.47 %) |
Feb 09 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 31.97 | 5,000 | 159,850 | 5,407 | 407 to 5.4 K (+1,228.50 %) |
Jan 24 2005 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | A | 49.87 | 6,000 | 299,220 | 201,000 | |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 31.97 | 5,000 | 159,850 | 195,000 | |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | A | 47.77 | 50,000 | 2,388,500 | 200,000 | |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 50.89 | 5,000 | 254,466 | 407 | 5.4 K to 407 (-92.47 %) |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 31.97 | 5,000 | 159,850 | 5,407 | 407 to 5.4 K (+1,228.50 %) |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | M | 31.97 | 5,000 | 159,850 | 195,000 | |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Option Exercise | A | 47.77 | 50,000 | 2,388,500 | 200,000 | |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Sell | S | 50.89 | 5,000 | 254,466 | 407 | 5.4 K to 407 (-92.47 %) |
Nov 12 2004 | RMD | RESMED INC | Gallahue Kieran | President, Global | Buy | M | 31.97 | 5,000 | 159,850 | 5,407 | 407 to 5.4 K (+1,228.50 %) |
Page: 1